Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
13%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
3
21%
Ph not_applicable
2
14%
Ph phase_4
4
29%
Ph phase_3
3
21%
Ph phase_1
2
14%

Phase Distribution

2

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
3(21.4%)
Phase 4Post-market surveillance
4(28.6%)
N/ANon-phased studies
2(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(4)

Detailed Status

Completed8
unknown4
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 23 (21.4%)
Phase 33 (21.4%)
Phase 44 (28.6%)
N/A2 (14.3%)

Trials by Status

terminated17%
unknown429%
completed857%
not_yet_recruiting17%

Recent Activity

0 active trials
Showing 5 of 14
completedphase_3

The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment

NCT06684626
completedphase_1

Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention

NCT06017479
not_yet_recruitingnot_applicable

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

NCT06049758
completedphase_1

Bioequivalence Study of Levomerc 500 mg Tablets

NCT05339295
completedphase_2

Short Compared With Standard Duration of Antibiotic Treatment for AECOPD

NCT03698682
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06684626Phase 3

The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment

Completed
NCT06017479Phase 1

Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention

Completed
NCT06049758Not Applicable

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

Not Yet Recruiting
NCT05339295Phase 1

Bioequivalence Study of Levomerc 500 mg Tablets

Completed
NCT03698682Phase 2

Short Compared With Standard Duration of Antibiotic Treatment for AECOPD

Completed
NCT03201796Phase 2

Prulifloxacin in Chronic Bacterial Prostatitis (CBP)

Completed
NCT04107194Phase 3

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

Unknown
NCT04626193Phase 4

LOAD VS Levofloxacine Concomitant

Unknown
NCT02067780Phase 3

Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD

Completed
NCT04348786Phase 4

Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori

Completed
NCT04352062Not Applicable

Melatonin Supplementation in Postmenopausal Women With H. Pylori-associated Dyspepsia

Completed
NCT04090021Phase 4

Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.

Unknown
NCT03555526Phase 4

Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection

Unknown
NCT01081964Phase 2

Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

Terminated

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14